Evaluation of the PBR/TSPO Radioligand [(18)F]DPA-714 in a Rat Model of Focal Cerebral Ischemia

Overview

Journal J Cereb Blood Flow Metab

Publisher Sage Publications

Specialties Cardiology & Vascular Diseases
Endocrinology
Neurology

Date 2009 Oct 2

PMID 19794397

Citations 99

Authors

Abraham Martin

Raphael Boisgard

Benoit Theze

Nadja Van Camp

Bertrand Kuhnast

Annelaure Damont

Michael Kassiou

Frederic Dolle

Bertrand Tavitian

Affiliations

Soon will be listed here.

Abstract

Focal cerebral ischemia leads to an inflammatory reaction involving an overexpression of the peripheral benzodiazepine receptor (PBR)/18-kDa translocator protein (TSPO) in the cerebral monocytic lineage (microglia and monocyte) and in astrocytes. Imaging of PBR/TSPO by positron emission tomography (PET) using radiolabeled ligands can document inflammatory processes induced by cerebral ischemia. We performed in vivo PET imaging with [(18)F]DPA-714 to determine the time course of PBR/TSPO expression over several days after induction of cerebral ischemia in rats. In vivo PET imaging showed significant increase in DPA (N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide) uptake on the injured side compared with that in the contralateral area on days 7, 11, 15, and 21 after ischemia; the maximal binding value was reached 11 days after ischemia. In vitro autoradiography confirmed these in vivo results. In vivo and in vitro [(18)F]DPA-714 binding was displaced from the lesion by PK11195 and DPA-714. Immunohistochemistry showed increased PBR/TSPO expression, peaking at day 11 in cells expressing microglia/macrophage antigens in the ischemic area. At later times, a centripetal migration of astrocytes toward the lesion was observed, promoting the formation of an astrocytic scar. These results show that [(18)F]DPA-714 provides accurate quantitative information of the time course of PBR/TSPO expression in experimental stroke.

Citing Articles

Characteristics of TSPO expression in marmoset EAE.

Falk I, Maric D, Leibovitch E, Sati P, Lefeuvre J, Luciano N J Neuroinflammation. 2025; 22(1):19.

PMID: 39871344 PMC: 11773908. DOI: 10.1186/s12974-025-03343-4.

Hemodynamics in chronic pain: A pathway to multi-modal health risks.

Davydov D, Galvez-Sanchez C, Reyes del Paso G PLoS One. 2024; 19(12):e0315341.

PMID: 39656693 PMC: 11630596. DOI: 10.1371/journal.pone.0315341.

Role of Microglia in Stroke.

Cipriani R, Domerq M, Martin A, Matute C Adv Neurobiol. 2024; 37:405-422.

PMID: 39207705 DOI: 10.1007/978-3-031-55529-9_23.

The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1.

Li Y, Chen L, Sottas C, Raul M, Patel N, Bijja J Metabolism. 2024; 159:155942.

PMID: 38871077 PMC: 11374472. DOI: 10.1016/j.metabol.2024.155942.

Absence in CX3CR1 receptor signaling promotes post-ischemic stroke cognitive function recovery through suppressed microglial pyroptosis in mice.

Ge Y, Yang J, Chen J, Dai M, Dou X, Yao S CNS Neurosci Ther. 2024; 30(2):e14551.

PMID: 38421089 PMC: 10850801. DOI: 10.1111/cns.14551.

References

Banati R, Newcombe J, Gunn R, Cagnin A, Turkheimer F, Heppner F . The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000; 123 ( Pt 11):2321-37. DOI: 10.1093/brain/123.11.2321. View

Gerhard A, Schwarz J, Myers R, Wise R, Banati R . Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005; 24(2):591-5. DOI: 10.1016/j.neuroimage.2004.09.034. View

Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, Okauchi T . Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007; 1157:100-11. DOI: 10.1016/j.brainres.2007.04.054. View

Kreutzberg G . Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996; 19(8):312-8. DOI: 10.1016/0166-2236(96)10049-7. View

Jander S, Schroeter M, Peters O, Witte O, Stoll G . Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab. 2001; 21(3):218-25. DOI: 10.1097/00004647-200103000-00005. View

Price C, Wang D, Menon D, Guadagno J, Cleij M, Fryer T . Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke. 2006; 37(7):1749-53. DOI: 10.1161/01.STR.0000226980.95389.0b. View

Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R . In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport. 2000; 11(13):2957-60. DOI: 10.1097/00001756-200009110-00025. View

Justicia C, Martin A, Rojas S, Gironella M, Cervera A, Panes J . Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab. 2005; 26(3):421-32. DOI: 10.1038/sj.jcbfm.9600198. View

Le Goascogne C, Eychenne B, Tonon M, Lachapelle F, Baumann N, Robel P . Neurosteroid progesterone is up-regulated in the brain of jimpy and shiverer mice. Glia. 1999; 29(1):14-24. DOI: 10.1002/(sici)1098-1136(20000101)29:1<14::aid-glia2>3.3.co;2-e. View

10.

Myers R, Manjil L, Frackowiak R, Cremer J . [3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci Lett. 1991; 133(1):20-4. DOI: 10.1016/0304-3940(91)90047-w. View

11.

Baron J, Barre L, Travere J, Speckel D, Camsonne R, MacKenzie E . Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. Eur J Pharmacol. 1991; 200(2-3):347-51. DOI: 10.1016/0014-2999(91)90594-g. View

12.

Castedo M, Perfettini J, Kroemer G . Mitochondrial apoptosis and the peripheral benzodiazepine receptor: a novel target for viral and pharmacological manipulation. J Exp Med. 2002; 196(9):1121-5. PMC: 2194100. DOI: 10.1084/jem.20021758. View

13.

Belayev L, Busto R, Zhao W, Ginsberg M . Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 1996; 739(1-2):88-96. DOI: 10.1016/s0006-8993(96)00815-3. View

14.

James M, Fulton R, Vercoullie J, Henderson D, Garreau L, Chalon S . DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med. 2008; 49(5):814-22. DOI: 10.2967/jnumed.107.046151. View

15.

Chauveau F, Van Camp N, Dolle F, Kuhnast B, Hinnen F, Damont A . Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med. 2009; 50(3):468-76. DOI: 10.2967/jnumed.108.058669. View

16.

Chen M, Baidoo K, Verina T, Guilarte T . Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain. 2004; 127(Pt 6):1379-92. DOI: 10.1093/brain/awh161. View

17.

Rojas S, Martin A, Arranz M, Pareto D, Purroy J, Verdaguer E . Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab. 2007; 27(12):1975-86. DOI: 10.1038/sj.jcbfm.9600500. View

18.

Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F . Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol. 2001; 29(5-6):307-26. DOI: 10.1023/a:1007152904926. View

19.

Chelli B, Falleni A, SALVETTI F, Gremigni V, Lucacchini A, Martini C . Peripheral-type benzodiazepine receptor ligands: mitochondrial permeability transition induction in rat cardiac tissue. Biochem Pharmacol. 2001; 61(6):695-705. DOI: 10.1016/s0006-2952(00)00588-8. View

20.

Chen M, Guilarte T . Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008; 118(1):1-17. PMC: 2453598. DOI: 10.1016/j.pharmthera.2007.12.004. View